Inogen

Inogen EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inogen (INGN) as of Oct 6, 2026 is -25.29 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -38.19 M USD — a change of -33.78% (higher).

EBITDA

-25.29 MUSD

YoY

-33.78%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inogen is 2026 -25.29 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inogen was 2025 -38.19 M USD. It decreases by -33.78% higher compared to the previous year.

The Inogen EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
37.89 M USD
Jan 1, 2019
19.79 M USD
Jan 1, 2020
-12.03 M USD
Jan 1, 2021
18.04 M USD
Jan 1, 2022
-76.74 M USD
Jan 1, 2023
-108.18 M USD
Jan 1, 2024
-38.19 M USD
Jan 1, 2025
-25.29 M USD
The Inogen EBITDA history
YEAREBITDAYoY
-25.29 MUSD-33.78%
-38.19 MUSD-64.70%
-108.18 MUSD+40.97%
-76.74 MUSD-525.40%
18.04 MUSD-250.02%
-12.03 MUSD-160.77%
19.79 MUSD-47.78%
37.89 MUSD+37.34%
27.59 MUSD+20.67%
22.86 MUSD+51.91%
15.05 MUSD+43.19%
10.51 MUSD—
Access this data via the Eulerpool API

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inogen stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inogen is -25.29 M USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inogen changed from -38.19 M USD to -25.29 M USD, representing a -33.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Inogen since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Inogen historically and in real time.

Access this data via the Eulerpool API

Income Statement — Inogen

All Key Metrics — Inogen